LEP and endometrial cancer: Based on our observations, it can be observed that under the influence of the addition of cisplatin to the endometrial cancer cells of the Ishikawa line, the expression of leptin is silenced, due to the fact, it seems that establishing oncological therapy of endometrial cancer on cisplatin is a reasonable action.